Skip to search formSkip to main contentSkip to account menu

UR 1505

Known as: UR-1505, UR1505 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
UR-1505, ¿un nuevo salicilato para la enfermedad inflamatoria intestinal?
La enfermedad de Crohn (EC) y la colitis ulcerosa (CU) son enfermedades inflamatorias intestinales (EII) cronicas humanas, en… 
2008
2008
UR‐1505, a salicylate able to selectively block T‐cell activation, shows intestinal anti‐inflammatory activity in the chronic phase of the DSS model of rat colitis
Background: UR‐1505 is a novel salicylate derivative compound that has been demonstrated to selectively down‐regulate T‐cell… 
2008
2008
P268 UR-1505, A New Salicylate Derivative, Shows Intestinal Anti-Inflammatory Activity in the Chronic Phase of the DSS Model of Rat Colitis
2007
2007
The intestinal anti-inflammatory effects of the novel agent UR-1505 in the TNBS model of rat colitis are mediated by T-lymphocyte inhibition.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)